"Baptist Health Hardin is an integrated system of providers and facilities serving approximately 400,000 resident in 10 Central Kentucky counties (Hardin, LaRue, Meade, Breckinridge, Grayson, Nelson, Hart, Bullitt, Green and Taylor)."

During the past decade, Hardin Memorial Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 22 clinical trials were completed, i.e. on average, 62.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 19 clinical trials were completed. i.e. 316.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hardin Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NRG Oncology" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hardin Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hardin Memorial Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (5 trials), "Stage IIIA Breast Cancer AJCC v7" (4 trials) and "Stage IIIC Breast Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Hardin Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Hardin Memorial Hospital" are "Other" (36 trials), "Drug" (34 trials), "Biological" (14 trials), "Procedure" (8 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (11 trials), "Docetaxel" (7 trials), "Carboplatin" (6 trials) and "Nivolumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hardin Memorial Hospital" are 34 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Hardin Memorial Hospital". undefined are not yet recruiting, 8 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hardin Memorial Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hardin Memorial Hospital, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Hardin Memorial Hospital has several departments that took part in Clinical trials: "Central Cardiology Associates" - 5 trials